The inspectors identified quality control lapses at the company's California animal research facility. A similar inspection at Neuralink's Texas facility did not find problems, according to agency records. Those visits took place last year from June 12-22, and represent the FDA's sole inspections of Neuralink facilities on record.
from Tech-Economic Times
via IFTTT
No comments:
Post a Comment